Last Updated: December, 2025
Trusted by 200+ Clients
Compare & Choose the Right Report Version for You
How to Order Your Report?
The report provides a detailed analysis essential for establishing an Eprosartan production plant. It encompasses all critical aspects necessary for Eprosartan production, including the cost of Eprosartan production, Eprosartan plant cost, Eprosartan production costs, and the overall Eprosartan production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Eprosartan production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Eprosartan is an angiotensin II receptor antagonist mainly used in the treatment of hypertension. It is a medicinal compound that is used to manage high blood pressure and support cardiovascular health. It works by helping blood vessels relax and reducing the workload on the heart by preventing the action of certain chemicals that tighten blood vessels. It also finds its application in reducing the risk of strokes, heart attacks, and kidney problems, due to its ability to lower blood pressure.
It is usually taken orally in tablet form and can be used alone or in combination with other antihypertensive medications. In clinical practice, it is especially used for patients who are unable to tolerate ACE inhibitors. Moreover, it is often used in research related to kidney protection and cardiovascular function in both clinical and scientific settings.
The primary factor that drives the market for Eprosartan is its application as an antihypertensive agent for managing hypertension, which significantly supports its demand in the medical sector. Its application as a valuable drug in the management of long-term cardiovascular health largely promotes its demand in the medical and healthcare sectors. Its usage as an alternative option in long-term treatment plans for hypertension and related cardiovascular conditions also fuels its demand in the pharmaceutical industry. Its involvement in combination with other antihypertensive medications to reduce the risk of heart-related conditions further contributes to its demand in the medical and pharmaceutical industries.
Its effectiveness in lowering blood pressure and reducing the risk of heart attacks and strokes makes it a highly sought-after commodity among healthcare industries. Additionally, industrial Eprosartan procurement is influenced by factors such as the cost and consistent availability of key raw materials, adherence to stringent regulatory standards, and evolving environmental and safety protocols. Furthermore, advancements in formulation technologies, supplier reliability, compliance with international quality certifications and efficient distribution networks also play a significant role in shaping its market and procurement practices.
According to the Eprosartan production plant project report, the major raw materials for Eprosartan production include Methyl 4-(bromomethyl)benzoate, 5-Chloro-2-propylimidazole, and Monomethyl ester of 2-thenylmalonate.
The extensive Eprosartan production cost report consists of the following industrial production process:
Eprosartan belongs to a class of drugs known as angiotensin II receptor blockers (ARBs). It appears as a white to off white crystalline powder that is practically odourless. The molecular formula of the compound is C23H24N2O4S, and its molar mass is about 424.5 g/mol. It is a solid at room temperature and shows very low solubility in water, but it is more soluble in organic solvents such as methanol and ethanol. The compound does not have a defined boiling point as it decomposes upon heating, and its melting point is around 248-250 degree Celsius. It contains a biphenyl tetrazole-like structure with a sulfonyl group, which contributes to its stability and pharmacological activity. It is generally stable under normal conditions but should be stored away from excessive heat and moisture between 2-8 degree Celsius. It is advised to follow standard protective measures during handling the compound in pharmaceutical or laboratory settings, as exposure or improper handling may cause irritation.
Eprosartan Production Cost Report
Choose What's Right for You
Pay Via
| Particulars | Details |
|---|---|
| Product Name | Eprosartan |
| Scope | Production Process: Process Flow, Material Flow, Material Balance Raw Material and Product Specifications: Raw Material Consumption, Product and Co-product Generation Land and Site Cost: Offsites/Civil Works, Equipment Cost, Auxiliary Equipment Costs, Contingency, Engineering and Consulting Charges, Working Capital Variable Cost: Raw Material, Utilities, Other Variable Costs Fixed Cost: Labor Requirements and Wages, Overhead Expenses, Maintenance Charges, Other Fixed Costs Financing Costs: Interest on Working Capital, Interest on Loans Other Costs: Depreciation Charges, General Sales and Admin Cost |
| Currency | US$ (Data can also be provided in the local currency) |
| Pricing and Purchase Options | Basic: US$ 2499 Premium: US$ 3499 Enterprise: US$ 4799 |
| Customization Scope | The report can be customized as per the requirement of the customer |
| Post-Sale Analysts Report | 10-12 weeks of post-purchase analyst support after report delivery for any queries from the deliverable |
| Delivery Format | PDF and Excel format through email (editable version in PPT/Word format of the report can be also provided on special request) |
At Procurement Resource, we not only focus on optimizing the should cost of production for Eprosartan but also provide our clients with extensive intel and rigorous information on every aspect of the production process. By utilizing a comprehensive cost model, we help you break down expenses related to raw materials, labor, and technology, offering clear pathways to savings. We also assist in evaluating the capital expenditure (CAPEX) and operating expenses (OPEX), which are often measured as cost per unit of production, such as USD/MT, ensuring that your financial planning is aligned with industry benchmarks.
We offer valuable insights on the top technology providers, in-depth supplier database, and best manufacturers, helping you make informed decisions to improve efficiency. Additionally, we design the most feasible layout for your production needs, ensuring the entire process runs smoothly. By minimizing the cash cost of production, we ensure that you stay competitive while securing long-term profitability in the growing Eprosartan market. Partnering with Procurement Resource guarantees that every aspect of your production is cost-efficient, advanced, and tailored to your specific requirements.
Vishakha Agrawal
Lead - Social & Development Research
Delivering procurement intelligence and supply chain analytics across healthcare, FMCG, and chemicals sectors, with expertise in cost modeling, vendor mapping, and spend optimization to support data-driven sourcing decisions and procurement outcomes.
Need more help?
Still Need Help?
